Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis

16Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Galactomannan Enzyme Immunoassay (GM-EIA) is proved to be a cornerstone in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA), its use is limited in middle and low-income countries, where the application of simple and rapid test, including Galactomannan Lateral Flow Assay (GM-LFA), is highly appreciated. Despite such merits, limited studies directly compared GM-LFA with GM-EIA. Herein we compared the diagnostic features of GM-LFA, GM-EIA and bronchoalveolar lavage (BAL) culture for CAPA diagnosis in Iran, a developing country. Materials/Methods: Diagnostic performances of GM-LFA and GM-EIA in BAL (GM indexes ≥1) and serum (GM indexes >0.5), i.e. sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) and areas under the curve (AUC), were evaluated using BAL (n = 105) and serum (n = 101) samples from mechanically ventilated COVID-19 patients in intensive care units. Patients were classified based on the presence of host factors, radiological findings and mycological evidences according to 2020 ECMM/ISHAM consensus criteria for CAPA diagnosis. Results: The Aspergillus GM-LFA for serum and BAL samples showed a sensitivity of 56.3% and 60.6%, specificity of 94.2% and 88.9%, PPV of 81.8% and 71.4%, NPV of 82.3% and 83.1%, when compared with BAL culture, respectively. GM-EIA showed sensitivities of 46.9% and 54.5%, specificities of 100% and 91.7%, PPVs of 100% and 75%, NPVs of 80.2% and 81.5% for serum and BAL samples, respectively. Conclusion: Our study found GM-LFA as a reliable simple and rapid diagnostic tool, which could circumvent the shortcomings of culture and GM-EIA and be pivotal in timely initiation of antifungal treatment.

References Powered by Scopus

Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study

698Citations
N/AReaders
Get full text

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

643Citations
N/AReaders
Get full text

Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study

202Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Metagenomic next-generation sequencing for detecting Aspergillosis pneumonia in immunocompromised patients: a retrospective study

15Citations
N/AReaders
Get full text

Point-of-care testing for viral-associated pulmonary aspergillosis

12Citations
N/AReaders
Get full text

Implementation of Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis in European Hospitals: A Survey from Belgium and a Literature Review of Test Performances in Different Patient Populations

7Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Ghazanfari, M., Yazdani Charati, J., Davoodi, L., Arastehfar, A., Moazeni, M., Abastabar, M., … Hedayati, M. T. (2022). Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis. Mycoses, 65(10), 960–968. https://doi.org/10.1111/myc.13518

Readers' Seniority

Tooltip

Professor / Associate Prof. 3

38%

Researcher 3

38%

Lecturer / Post doc 1

13%

PhD / Post grad / Masters / Doc 1

13%

Readers' Discipline

Tooltip

Medicine and Dentistry 4

44%

Agricultural and Biological Sciences 3

33%

Biochemistry, Genetics and Molecular Bi... 1

11%

Environmental Science 1

11%

Save time finding and organizing research with Mendeley

Sign up for free